doi: 10.1186/1479-5876-12-20 400 FeganKGBehanPOBellEJ
The dasatinib-plus- quercetin combination cleared senescent cells in a first-in-human trial, and a small feasibility trial is testing it in Alzheimers, though the brain evidence is early
But the blood sugar test quietly sitting in their annual lab results may be doing far more damage than a slightly low T level ever could
When the protocol is built around your history and supervised, many patients describe feeling like their body finally responds again
In short, semaglutide answers what does sustained GLP-1 activation do? while tirzepatide answers what happens when GLP-1 and GIP are engaged together? That distinction, more than any single number, is the heart of the comparison
Marco D.July 5, 2026 first time trying a copper peptide and honestly the dropper is so much easier than the pump my old serum had, no wasting half of it everywhere